MarketPeel
Insider Trading Intelligence
RA

Robert Eugene JR Anderson

SAVA
DIRECTOR · FILANA THERAPEUTICS, INC. · CIK 0002001911
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$24.9K
COMPANIES
1
ACTIVE SINCE
Dec 2023
HOLDINGS NOW
8,600
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Robert Eugene JR Anderson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+4.48%+1.73%+2.76%+2.76%
14d1+100.00%+10.35%+2.23%+8.12%+8.12%
30d1+0.00%-23.10%+3.24%-26.34%-26.34%
60d1+0.00%-24.14%+3.07%-27.20%-27.20%
90d1+0.00%-25.69%+2.04%-27.73%-27.73%
180d1
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SAVA · 8,600 shares · as of Nov 24, 2025
06,62513,25019,87526,50020242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 4 buys / 0 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
8,600$2.90$24.9K8,600Nov 24, 2025Nov 25, 2025View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,50026,500May 23, 2025May 27, 2025View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000May 9, 2024May 13, 2024View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Dec 6, 2023Dec 7, 2023View →
Other insiders · SAVA
Loading peer insiders…
About this filer
CIK 0002001911
ROLE
Director
PRIMARY
SAVA
COMPANIES
1
ACTIVE SINCE
Dec 2023
MARKETPEEL · /INSIDER/0002001911DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback